Brain Cancer
Page 1 • 2 itemsGlobal brain cancer market intelligence for pharma BD, investors & analysts. Track drug development, clinical trials, and regulatory approvals.
BriaCell Bria-OTS+ Shows Preserved Quality of Life in Phase 3 Metastatic Breast Cancer Trial at AACR 2026
BriaCell's Bria-OTS+ maintains quality of life in heavily pretreated metastatic breast cancer patients, with new biomarker data presented at AACR 2026.
TME Pharma NOX-A12 Triple Therapy Shows Promise in Brain Cancer GLORIA Trial Published in Nature Communications
TME Pharma announces Nature Communications publication of NOX-A12 triple therapy Phase 1/2 GLORIA trial results for brain cancer treatment.